药监局-话题@MedSci

#药监局#

232篇内容 | 1869人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1301534, encodeId=25e0130153401, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=药监局将36种药品转换为非处方药品, objectType=article, longId=11214, objectId=2b6211214d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b6211214d7, replyNumber=0, likeNumber=31, createdTime=2012-11-23, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b6211214d7, moduleTitle=药监局将36种药品转换为非处方药品, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b6211214d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301535, encodeId=39981301535f0, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=药监局：警惕他汀类药品血糖异常不良反应及与HIV蛋白酶抑制剂的相互作用, objectType=article, longId=11215, objectId=8f7e1121571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f7e1121571, replyNumber=0, likeNumber=24, createdTime=2012-11-23, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f7e1121571, moduleTitle=药监局：警惕他汀类药品血糖异常不良反应及与HIV蛋白酶抑制剂的相互作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f7e1121571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301533, encodeId=8a06130153306, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=药监局加强药用玻璃包装注射剂药品监督管理, objectType=article, longId=10964, objectId=94d21096449, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94d21096449, replyNumber=0, likeNumber=36, createdTime=2012-11-18, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94d21096449, moduleTitle=药监局加强药用玻璃包装注射剂药品监督管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94d21096449)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301532, encodeId=c2891301532b4, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=药监局再征《保健食品新功能产品申报与审评规定》意见, objectType=article, longId=10923, objectId=44b01092378, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44b01092378, replyNumber=0, likeNumber=27, createdTime=2012-11-11, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44b01092378, moduleTitle=药监局再征《保健食品新功能产品申报与审评规定》意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44b01092378)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301531, encodeId=915413015310e, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=药监局印发《药品和医疗器械行政处罚裁量适用规则》, objectType=article, longId=10807, objectId=dc4a1080ead, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc4a1080ead, replyNumber=0, likeNumber=45, createdTime=2012-11-08, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc4a1080ead, moduleTitle=药监局印发《药品和医疗器械行政处罚裁量适用规则》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc4a1080ead)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301530, encodeId=c34d1301530f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=药监局修订雷公藤中成药说明书, objectType=article, longId=10590, objectId=0001105906d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0001105906d, replyNumber=0, likeNumber=47, createdTime=2012-10-27, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0001105906d, moduleTitle=药监局修订雷公藤中成药说明书, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0001105906d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301529, encodeId=b1901301529f3, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局酝酿OTC大众广告禁令, objectType=article, longId=10022, objectId=dcd01002212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcd01002212, replyNumber=0, likeNumber=34, createdTime=2012-10-01, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcd01002212, moduleTitle=国家药监局酝酿OTC大众广告禁令, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcd01002212)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301528, encodeId=1585130152825, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=药监局提示脉络宁注射液不良反应, objectType=article, longId=7382, objectId=a78fe38209, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a78fe38209, replyNumber=0, likeNumber=0, createdTime=2012-06-28, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a78fe38209, moduleTitle=药监局提示脉络宁注射液不良反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a78fe38209)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301527, encodeId=b37e130152eec, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=药监局修订吡格列酮说明书内容, objectType=article, longId=6166, objectId=e914616618, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e914616618, replyNumber=0, likeNumber=26, createdTime=2012-05-18, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e914616618, moduleTitle=药监局修订吡格列酮说明书内容, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e914616618)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301526, encodeId=a7821301526f8, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=美食品药监局批准Stendra用于治疗勃起功能障碍, objectType=article, longId=5902, objectId=f2255902e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2255902e3, replyNumber=0, likeNumber=31, createdTime=2012-05-06, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2255902e3, moduleTitle=美食品药监局批准Stendra用于治疗勃起功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2255902e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301525, encodeId=4b47130152571, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=药监局修订香丹注射液说明书, objectType=article, longId=5370, objectId=b02d53e06b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b02d53e06b, replyNumber=0, likeNumber=21, createdTime=2012-04-18, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b02d53e06b, moduleTitle=药监局修订香丹注射液说明书, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b02d53e06b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301524, encodeId=b4b71301524df, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=尹力担任国家药监局局长, objectType=article, longId=4135, objectId=b8d74135dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8d74135dd, replyNumber=0, likeNumber=25, createdTime=2012-02-26, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8d74135dd, moduleTitle=尹力担任国家药监局局长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8d74135dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药监局

2020-05-29

xuyu (审核中...)

前往app查看评论内容

#药监局#

药监局将36种药品转换为非处方药品

2012-11-23

xuyu (审核中...)

前往app查看评论内容

#药监局#

药监局：警惕他汀类药品血糖异常不良反应及与HIV蛋白酶抑制剂的相互作用

2012-11-23

xuyu (审核中...)

前往app查看评论内容

#药监局#

药监局加强药用玻璃包装注射剂药品监督管理

2012-11-18

xuyu (审核中...)

前往app查看评论内容

#药监局#

药监局再征《保健食品新功能产品申报与审评规定》意见

2012-11-11

xuyu (审核中...)

前往app查看评论内容

#药监局#

药监局印发《药品和医疗器械行政处罚裁量适用规则》

2012-11-08

xuyu (审核中...)

前往app查看评论内容

#药监局#

药监局修订雷公藤中成药说明书

2012-10-27

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局酝酿OTC大众广告禁令

2012-10-01

xuyu (审核中...)

前往app查看评论内容

#药监局#

药监局提示脉络宁注射液不良反应

2012-06-28

xuyu (审核中...)

前往app查看评论内容

#药监局#

药监局修订吡格列酮说明书内容

2012-05-18

xuyu (审核中...)

前往app查看评论内容

#药监局#

美食品药监局批准Stendra用于治疗勃起功能障碍

2012-05-06

xuyu (审核中...)

前往app查看评论内容

#药监局#

药监局修订香丹注射液说明书

2012-04-18

xuyu (审核中...)

前往app查看评论内容

#药监局#

尹力担任国家药监局局长

2012-02-26

科室
- - 订阅+
  - 更多科室
工具
服务